Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(50%)
Results Posted
0%(0 trials)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

2

all time

Status Distribution
Active(1)
Completed(1)

Detailed Status

Completed1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
2
Active
1
Success Rate
100.0%

Trials by Status

completed150%
active_not_recruiting150%

Recent Activity

1 active trials
Showing 2 of 2
active_not_recruiting

Transcriptional Responses as an Indicator of Individualised Responses to Radiation Effects (RTGene 2)

NCT03809377
completed

Feasibility Study Testing Transcriptional Responses as an Indicator of Individualised Responses to Radiation Effects

NCT02780375

Clinical Trials (2)

Showing 2 of 2 trials
NCT03809377

Transcriptional Responses as an Indicator of Individualised Responses to Radiation Effects (RTGene 2)

Active Not Recruiting
NCT02780375

Feasibility Study Testing Transcriptional Responses as an Indicator of Individualised Responses to Radiation Effects

Completed

All 2 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
2